PLANET® Dose is Selected by The French Public Hospitals for Targeted Radionuclide Therapies
- January 25, 2018
DOSIsoft SA has been selected, following a public tender, by the French public hospitals (CH and CHU), through their centralized purchasing organization UniHA, for the supply, installation and commissioning services of PLANET® Dose Software Suite dedicated to Targeted Radionuclide Therapies (90Yttrium microspheres SIRT / 177Lutetium based treatments) in Nuclear Medicine.
Securing the Radiation Therapy Patient Treatment Path: A DOSIsoft – UNICANCER Scientific Partnership to Go One Step Further
- December 7, 2017
DOSIsoft and UNICANCER, which groups together all French Comprehensive Cancer Centers (FCCCs), announce a scientific partnership, aiming at bringing an innovative solution to optimize patient safety in Radiation Therapy. This R&D partnership is established under the framework of the “iNNOV’Up Experimentation” program, led by the French Paris Region and managed by public investment bank Bpifrance.
DOSIsoft Contouring and Quality Assurance Radiation Therapy Solutions Selected by the French Public Hospitals
- September 15, 2017
Following a public tender, DOSIsoft SA has been selected by the French public hospitals (CH and CHU), through their centralized purchasing organization UniHA, for the supply, installation and commissioning services of Contouring and Quality Assurance Radiation Therapy Solutions. IMAgo and ThinkQA are the best suited solutions for Radiation Therapy centers in the world.
Release of ISOgray Proton Treatment Planning System with Pencil Beam Scanning Technique
- July 27, 2017
DOSIsoft SA announces the official release, with CE marking, on March 21st, 2017, of ISOgray Treatment Planning System (TPS) release 4.3 for proton therapy with active scanning beams (Pencil Beam Scanning). This significant milestone has been achieved through close collaboration with Institut Curie – Protontherapy Center of Orsay (ICPO) in France.
DOSIsoft Announces the New Release of PLANET® Dose, Complete Dosimetry Solution also for 177Lutetium-based Therapies
- June 9, 2017
DOSIsoft announces a new major release of its PLANET® Dose dosimetry solution for advanced radionuclide-based therapies. It includes specific features for 177Lu treatments, in particular related to the pharmacokinetic characteristics of such treatments. The new features include: multi time points elastic image registration, deformable propagation of Volume-Of-Interest, residence time calculation, dose computation, consolidation of multi-treatment stages and appropriate Dose-Volume histograms.
Gustave Roussy and DOSIsoft Collaborate on Big Data and Radiomics applied to Radiation Oncology
- May 18, 2017
Gustave Roussy and DOSIsoft SA collaborate on Big Data and Radiomics applied to radiation oncology. DOSIsoft carries out preliminary research and scientific collaborations on quantitative index and biomarker computation from multimodality imaging.
The Netherlands Cancer Institute Selects PLANET® Dose as their Dosimetry Solution for Radionuclide-based Therapies
- April 28, 2017
The Netherlands Cancer Institute (Antoni van Leeuwenhoek) has selected DOSIsoft PLANET® Dose as their dosimetry solution for Selective Internal Radiation Therapies (SIRT) with 90Y-microspheres and new radionuclide therapies, in particular for neuroendocrine tumors using 177Lu-peptide.
DOSIsoft Releases its Pretreatment QA Solution: EPIbeam
- November 29, 2016
DOSIsoft is proud to announce the official release of EPIbeam, with CE marking (European Conformity). This new solution is dedicated to the pre-treatment beam control for Patient Specific Quality Assurance, based on the use of the Electronic Portal Imaging Device (EPID).
DOSIsoft Creates a US Branch in Florida
- September 22, 2016
DOSIsoft Americas is located within the University of Miami’s Health District, the second largest Health District in the USA and is managed by Mr. Jean-Elie KAFROUNI, Head of US Operations. It will specifically serve the US market as well as support the whole North, Central and South America requirements.
Marc Uszynski is Nominated as DOSIsoft’s Chief Executive Officer
- September 15, 2016
Passionated by high-tech, Marc Uszynski takes up a new challenge by joining DOSIsoft, company with a strong growth potential offering software solutions in radiotherapy and molecular imaging.